β-Chemokine MDC and HIV-1 Infection
- 24 July 1998
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 281 (5376) , 487
- https://doi.org/10.1126/science.281.5376.487a
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavageProceedings of the National Academy of Sciences, 1998
- Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated CleavageThe Journal of Experimental Medicine, 1997
- Inhibition of HIV-1 Infection by the β-Chemokine MDCScience, 1997
- Angiogenic and HIV-Inhibitory Functions of KSHV-Encoded ChemokinesScience, 1997
- A Broad-Spectrum Chemokine Antagonist Encoded by Kaposi's Sarcoma-Associated HerpesvirusScience, 1997
- Unwelcomed Guests with Master Keys: How HIV Uses Chemokine Receptors for Cellular EntryVirology, 1997
- Co-receptors for HIV-1 entryCurrent Opinion in Immunology, 1997
- Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer CellsThe Journal of Experimental Medicine, 1997
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995